【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Pancreatic Cancer Overview 11
3 Products under Development 12
3.1 Pancreatic Cancer – Pipeline Products by Stage of Development 12
3.2 Pancreatic Cancer – Pipeline Products by Territory 13
3.3 Pancreatic Cancer – Pipeline Products by Regulatory Path 14
3.4 Pancreatic Cancer – Pipeline Products by Estimated Approval Date 15
4 Pancreatic Cancer – Pipeline Products under Development by Companies 16
4.1 Pancreatic Cancer Companies – Pipeline Products by Stage of Development 16
4.2 Pancreatic Cancer – Pipeline Products by Stage of Development 19
5 Pancreatic Cancer Companies and Product Overview 21
5.1 A&G Pharmaceutical, Inc. Company Overview 21
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Abcodia Ltd. Company Overview 23
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Acobiom Company Overview 24
5.3.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Andraka Technologies, LLC Company Overview 25
5.4.1 Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Applied Proteomics, Inc. Company Overview 26
5.5.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Asuragen, Inc. Company Overview 27
5.6.1 Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 BioMarker Strategies, LLC Company Overview 28
5.7.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Biouniversa s.r.l. Company Overview 29
5.8.1 Biouniversa s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Cancer Research Technology Limited Company Overview 31
5.9.1 Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Cellmid Limited Company Overview 32
5.10.1 Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Cepheid Company Overview 33
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Chronix Biomedical, Inc. Company Overview 35
5.12.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Cleveland Diagnostics Inc. Company Overview 37
5.13.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.14 Clovis Oncology, Inc. Company Overview 38
5.14.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 CompanDX Ltd. Company Overview 40
5.15.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Courtagen Life Sciences, Inc. Company Overview 41
5.16.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 CS-Keys, Inc. Company Overview 42
5.17.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 Dartmouth College Company Overview 43
5.18.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Di.V.A.L Toscana srl Company Overview 45
5.19.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 Exact Sciences Corporation Company Overview 46
5.20.1 Exact Sciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
5.21 GeneFluidics Inc. Company Overview 48
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 German Cancer Research Center Company Overview 49
5.22.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 GlycoZym Company Overview 50
5.23.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Health Discovery Corporation Company Overview 51
5.24.1 Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Hebrew University of Jerusalem Company Overview 53
5.25.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 53
5.26 ImmunoCellular Therapeutics, Ltd. Company Overview 54
5.26.1 ImmunoCellular Therapeutics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
5.27 Immunomedics, Inc. Company Overview 56
5.27.1 Immunomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.28 Imperial College London Company Overview 58
5.28.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 58
5.29 IV Diagnostics, Inc. Company Overview 59
5.29.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.30 Matrix-Bio, Inc. Company Overview 60
5.30.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.31 Mayo Clinic Company Overview 61
5.31.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 61
5.32 MDNA Life Sciences, Inc. Company Overview 62
5.32.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.33 Merrimack Pharmaceuticals, Inc. Company Overview 63
5.33.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.34 Metanomics Health GmbH Company Overview 65
5.34.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 65
5.35 Milagen, Inc. Company Overview 66
5.35.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.36 Miraculins Inc. Company Overview 67
5.36.1 Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.37 NanoScale Corporation Company Overview 69
5.37.1 NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview 69
5.38 NatiMab Therapeutics S.r.l. Company Overview 70
5.38.1 NatiMab Therapeutics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 70
5.39 National Cheng-Kung University Hospital Company Overview 71
5.39.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
5.40 Neogenix Oncology, Inc. Company Overview 72
5.40.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.41 Onconome, Inc. Company Overview 73
5.41.1 Onconome, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.42 OPKO Health, Inc. Company Overview 75
5.42.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.43 Oxford Gene Technology Limited Company Overview 77
5.43.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.44 PeriRx LLC Company Overview 78
5.44.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 78
5.45 Precision Biologics, Inc. Company Overview 79
5.45.1 Precision Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.46 Proplex Technologies, Llc Company Overview 80
5.46.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 80
5.47 Protagen AG Company Overview 82
5.47.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 82
5.48 SDIX, LLC Company Overview 83
5.48.1 SDIX, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.49 Sienna Cancer Diagnostics Ltd Company Overview 85
5.49.1 Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.50 SomaLogic, Inc. Company Overview 86
5.50.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.51 Source MDx Company Overview 87
5.51.1 Source MDx Pipeline Products & Ongoing Clinical Trials Overview 87
5.52 Stanford University Company Overview 88
5.52.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 88
5.53 The Johns Hopkins University Company Overview 89
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 89
5.54 Thomas Jefferson University Company Overview 93
5.54.1 Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview 93
5.55 US Biomarkers, Inc. Company Overview 94
5.55.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.56 Viomics Inc. Company Overview 95
5.56.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.57 Vitatex Inc. Company Overview 96
5.57.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.58 VolitionRX Ltd. Company Overview 98
5.58.1 VolitionRX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
6 Pancreatic Cancer- Recent Developments 100
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107
【レポート販売概要】
■ タイトル：世界における膵臓癌検査製品のパイプライン動向2015■ 英文：Pancreatic Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0072EPD
■ 調査対象地域：グローバル
- ベビーカーの世界市場About Baby Stroller and Pram Strollers and prams are used to carry babies. There are different types of strollers and prams depending upon the weight and age of babies. Prams are specifically used to carry infants in lying position, while strollers are used to carry babies of age between one and four years in sitting position. Prams are heavier and bulkier than strollers. TechNavio’s analysts fore …
- 金属加工用流体の世界市場分析：製品別（ミネラル、合成、バイオベース）、用途別（ニート切削油、水溶性切削油、腐食防止油）、セグメント予測The global metalworking fluids market is expected to reach USD 11.99 billion by 2022, according to a new report by Grand View Research, Inc. Growing demand for metalworking fluids in automotives and heavy machinery owing to its properties of increasing efficiency is expected to drive market growth. Competitive pricing owing to large number of small suppliers in the market is expected to be a key f …
- 冷凍食品の世界市場2015-2019Technavio's research analyst predicts the global frozen food market to grow steadily at a CAGR of 4% during the forecast period. The rise in disposable income and the growing desire for convenience is driving the growth of this market. Consumers prefer ready to eat meals that can reduce their cooking and clean up time. Moreover, the ease of use associated with the packaging technique and the micro …
- 指紋センサの世界市場：スワイプセンサ、エリアセンサ、タッチセンサThe fingerprint sensors market is expected to reach USD 8.85 Billion by 2022, at a CAGR of 18.9% between 2016 and 2022. The growth of this market is propelled by government initiatives to adopt biometrics in various fields, increasing penetration of fingerprint sensors in smartphones, need for secured and simplified user access, growing adoption of mobile commerce, and increase usage of biometrics …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- プレフィルドシリンジの世界市場2015-2022According to Stratistics MRC, the Global Prefilled Syringes market is accounted for $4.45 billion in 2015 and is expected to reach $11.18 billion by 2022 growing at a CAGR of 14.0% during the forecast period. Rising prevalence of chronic diseases, technological advancements and rising number of biologics are the key factors fueling the market growth. On the other hand, stringent government regulat …
- 発電機レンタルの世界市場：契約件数および取引分析Global power rental contracts and agreements grew by 26% in 2015. This growth is attributed to continued growth of constructional & developmental activities and increasing demand-supply gap of electric power in emerging economies. The report segments global power rental contracts and deals on the basis of its strategy, which include contracts and agreements, investments and expansions, mergers and …
- 産業用エネルギー管理システムの世界市場：エネルギー管理ソフトウェア/装置/サービスAbout Energy Management System in Industrial Sector Energy management system for the Industrial sector is a system of computer-aided tools that help industries to monitor, control, and optimize their electrical loads. Energy management trend is shifting from hardware-based solutions to extensive software, hardware, and service-based solutions. This is achieved through a holistic view into the ener …
- SM Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- タンク断熱の世界市場予測（～2023年）“The tank insulation market is projected to register a CAGR of 4.5% during the forecast period.”The tank insulation market size is projected to grow from USD 5.2 billion in 2018 to USD 6.5 billion by 2023. Growth in chemical manufacturing capacities and huge production of oil are expected to drive the demand for tank insulations during the forecast period. However, fluctuating raw materials prices …
- 世界のポリミキシン市場2015Global Polymixin Industry Report 2015 is a professional and in-depth study on the current state of the Polymixin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Polymixin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key …
- スマートグリッド市場におけるクラウドコンピューティング技術Cloud Computing: Cornerstone of the Next Generation of Smart-Grid Information Technology Summary Cloud computing is emerging as an ideal method of hosting and providing services over the internet, and is available in the form of private, public, combined, or hybrid cloud deployment models. It has a number of benefits for smart grid applications, such as cost-effectiveness, scalability and flexibil …
- iPad in Healthcare: Challenges & OpportunitiesThe healthcare industry in the United States has been the sole industry keeping the moribund tablet computer market alive for several years. Although previous tablet-based computing devices have not enjoyed substantial consumer use computer-makers had thought they would, the healthcare industry's appetite for non-laptop portable computers can be traced back to the late 1990s, when technologists cr …
- 世界のベンチレーター（人工呼吸器）市場：医療機器パイプライン分析2016Ventilators - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ventilators - Medical Devices Pipeline Assessment, 2016" provides an overview of Ventilators currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews maj …
- シームテープの世界市場2019-2023Global Seam Tapes Market: About this market Technavio’s seam tapes market analysis considers sales from both polyurethane (PU) and polyvinyl chloride (PVC). Our analysis also considers the sales of seam tapes in APAC, Europe, North America, South America, and MEA. In 2018, the PU segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such a …
